Merger and Acquisition Scenario
Cambridge Antibody Tech. Group plc (ADR) (CATGY) and West Pharmaceutical Services Inc. (WST)
| Date: | Oct 03, 2006 |
|---|---|
| Format: | HTML |
| Price: | $250.00 |
Abstract
Revere Data's Merger & Acquisition Scenario Report offers independent, objective and insightful analysis into a hypothetical combination of Cambridge Antibody Tech. Group plc (ADR) (CATGY) with West Pharmaceutical Services Inc. (WST) . The Revere report begins by identifying Cambridge Antibody Tech. Group plc (ADR) products that are either complementary or overlapping to West Pharmaceutical Services Inc. products. Cambridge Antibody Tech. Group plc (ADR) suppliers are then displayed alongside West Pharmaceutical Services Inc. suppliers, with overlapping suppliers to both firms highlighted. Dependent suppliers to both companies are also displayed, including the percentage of dependent revenue if known. Top Cambridge Antibody Tech. Group plc (ADR) customers and top West Pharmaceutical Services Inc. customers, including overlapping customers, are also shown. The Revere report then includes key business relationship data in the area of strategic partnerships for each company. Additional content and features include Lines of Business Summaries, Product Summaries, Individual Cambridge Antibody Tech. Group plc (ADR) Product Line and West Pharmaceutical Services Inc. Product Line Details, Cambridge Antibody Tech. Group plc (ADR) Earnings and West Pharmaceutical Services Inc. Earnings Summaries, and pro forma financial statements. Revere Data Merger & Acquisition Scenario Reports are an essential source of competitive insight into an array of potential merger, acquisition, takeover, consolidation, rollup or other combination scenarios, with particular focus in the healthcare, biotechnology, information technology, finance and media sectors. Revere's extensive databases on key business relationships, product lines, focused sectors, and financial performance indicators provide a rich and integrated information source for investment banking, corporate finance, C-level executives, management consultants, marketing, and business intelligence professionals who want actionable answers and ideas in seconds.
Report Contents
- Summary
- Lines of Business Summary
- Product Summary
- Overlap & Complementary Sectors
- Sample Products in Similar Lines of Business
- Sample Products in Complementary Lines of Business
- Business Relationship Summary
- Top Key Suppliers
- Top Key Customers
- Key Financial Summary
- Individual Company Summary
- Focused Sector
- Revenue/Earnings Summary
- Business Description
- Product Summary
- Product Details
- Relationship Details
- Key Competitors
- Dependent Suppliers
- Key Customers
- Key Partners
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
Companies Mentioned in the Report
More Information:
Learn more about Merger and Acquisition Scenario Report.
Don't see the Scenario report you want? Request Merger and Acquisition Scenario Report »
Download Fact Sheet Merger and Acquisition Scenario (PDF)
Related Reports:
- Merger and Acquisition Scenario for West Pharmaceutical Services Inc. (WST) and Cambridge Antibody Tech. Group plc (ADR) (CATGY)
- Merger and Acquisition Scenario for West Pharmaceutical Services Inc. (WST) and PRA International (PRAI)
- Merger and Acquisition Scenario for West Pharmaceutical Services Inc. (WST) and Nordion Inc(USA) (NDZ)
- Merger and Acquisition Scenario for West Pharmaceutical Services Inc. (WST) and Emisphere Technologies Inc. (EMIS)